Aulin Sherry
CIK 0001862144
Chief Financial Officer
Filings
4
Latest Dec 19, 2024
Issuers covered
1
Showing
4 of 4
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +2.1% | +2.1% | +2.1% | +2.1% |
| 90 days | 2 | 100% | +10.6% | +10.6% | +10.6% | +10.6% |
| 180 days | 2 | 100% | +18.6% | +18.6% | +18.6% | +18.6% |
| 365 days | 2 | 0% | -9.9% | -9.9% | -9.9% | -9.9% |
Issuers
Companies where Aulin Sherry has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | 4 | Dec 19, 2024 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|